Tigeciclina en infecciones intraabdominales complicadas

Translated title of the contribution: Tigecycline in complicated intra-abdominal infections

Johanna Osorio, Juan Carlos Cataño, María Fernanda Jiménez, Jorge Alberto Cortés, Ernesto Martínez-Buitrago, Leonardo Arévalo Mora, Sandra Liliana Valderrama, Gustavo Roncancio, José Yesid Rodríguez, Carlos Arturo Álvarez-Moreno

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Objective: To assess current best evidence available to generate recommendations regarding the effectiveness and safety of tigecycline use in adults with complicated intra-abdominal infection (cIAIs). Materials and methods: We conducted a systematic review of published meta-analysis that evaluated tigecycline compared to other antimicrobials and included the indication of cIAI. Quality of the evidence was evaluated by using the SIGN tool (Scottish Intercollegiate Guidelines Network) according to GRADE, and final recommendations were assessed by a modified Delphi Method in order to develop a consensus. Results: Five meta-analyzes met the selection criteria comparing tigecycline with other antibiotic treatments in complicated intra-abdominal infection. Five randomized clinical trials comprised in these meta-analysis included 2711 patients that received at least one dose of antibiotic (1382 tigecycline and 1389 the comparator regimen), We found no statistically significant differences in the evaluated outcomes by comparing tigecycline with other antibiotics, including clinical and microbiologic efficacy, safety and drug related mortality Conclusion: In adult patients with cIAIs, the use of tigecycline as monotherapy is equivalent in effectiveness to other antimicrobial therapeutic options and does not represent an increase in mortality compared to other antibiotics.

Translated title of the contributionTigecycline in complicated intra-abdominal infections
Original languageSpanish
Pages (from-to)234-242
Number of pages9
Issue number4
StatePublished - 2017


Dive into the research topics of 'Tigecycline in complicated intra-abdominal infections'. Together they form a unique fingerprint.

Cite this